Warfarin Sodium
Product Images NDC 51138-062

10 FDA label images from Med-health Pharma, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Warfarin Sodium (NDC 51138-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Med-health Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Warfarin 01)

Chemical Structure (Warfarin 01)
Chemical structure of Warfarin Sodium showing its molecular components, including benzene rings and a sodium salt group, consistent with the active ingredient Warfarin Sodium.*
FDA Label Image

Principal Display Panel (1 mg Tablet Bottle Label)

Principal Display Panel (1 mg Tablet Bottle Label)
Warfarin Sodium Tablets, USP Crystalline 1 mg, supplied by Med-Health Pharma, LLC. The label indicates this is a package of 30 tablets with the NDC 51138-054-30. It is labeled as a highly potent anticoagulant with a warning about serious bleeding risks and advises not to use or dispense before reading accompanying directions. Storage instructions specify controlled room temperature (20°-25°C). Manufacturer noted as Taro Pharmaceutical Industries, Haifa Bay, Israel.*
FDA Label Image

Principal Display Panel (2 mg Tablet Bottle Label)

Principal Display Panel (2 mg Tablet Bottle Label)
Warfarin Sodium Tablets USP Crystalline 2 mg bottle label by Med-Health Pharma, LLC. The label shows a 30 tablet count with the NDC 51138-055-30. It includes a warning that warfarin is a highly potent anticoagulant with serious bleeding risks, and notes prescription restriction. Manufacturer info is provided for Taro Pharmaceutical Ind., Haifa Bay, Israel.*
FDA Label Image

Principal Display Panel (2.5 mg Tablet Bottle Label)

Principal Display Panel (2.5 mg Tablet Bottle Label)
Warfarin Sodium 2.5mg tablets packaging label from Med-Health Pharma, LLC. The label specifies 30 tablets of Warfarin Sodium 2.5mg USP crystalline, identified as a highly potent anticoagulant. The label includes storage instructions, dosage warnings emphasizing serious bleeding risks, and legal notices about federal distribution restrictions. Manufacturer details and contact information for repackaging by Med-Health Pharma, LLC, are also present.*
FDA Label Image

Principal Display Panel (3 mg Tablet Bottle Label)

Principal Display Panel (3 mg Tablet Bottle Label)
Warfarin Sodium Tablets 3 mg carton label from Med-Health Pharma, LLC. The package contains 30 tablets, marked as prescription only (Rx Only). The label includes storage instructions, dosage use reference, warnings about serious bleeding and overdose, and manufacturing and repackaging details. The product NDC is 51138-057-30.*
FDA Label Image

Principal Display Panel (4 mg Tablet Bottle Label)

Principal Display Panel (4 mg Tablet Bottle Label)
Warfarin Sodium Tablets, USP Crystalline 4 mg by Med-Health Pharma, LLC. The label states the product contains 30 tablets and is prescription only. It includes warnings about high potency anticoagulant effects and overdose risk, with instructions to refer to the accompanying package insert. Storage instructions specify controlled room temperature (20°-25°C). Manufacturer listed as Taro Pharmaceutical Ind., Haifa Bay, Israel, and repackaged by Med-Health Pharma, North Las Vegas, NV.*
FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Principal Display Panel (5 mg Tablet Bottle Label)
Warfarin Sodium 5 mg tablets packaging label from Med-Health Pharma, LLC. The label indicates it contains 30 tablets of Warfarin Sodium USP Crystalline at 5 mg strength. It includes dosage and storage instructions, a warning about serious bleeding risks, and manufacturer details for Taro Pharmaceutical Ind. It also shows the NDC code 51138-059-30 and states the product is prescription only.*
FDA Label Image

Principal Display Panel (6 mg Tablet Bottle Label)

Principal Display Panel (6 mg Tablet Bottle Label)
Warfarin Sodium Tablets USP Crystalline 6mg label from Med-Health Pharma, LLC. The label shows that this is a repackaged product originally manufactured by Taro Pharmaceutical Ind. It contains 30 tablets per package. The label includes a warning about serious bleeding risks from overdosage and states the product is Rx Only. Storage instructions specify controlled room temperature 20°-25°C (68°-77°F). Various lot and expiration fields are present but not filled in.*
FDA Label Image

Principal Display Panel (7.5 mg Tablet Bottle Label)

Principal Display Panel (7.5 mg Tablet Bottle Label)
Warfarin Sodium 7.5 mg tablet packaging label from Med-Health Pharma, LLC. The label indicates the product is USP crystalline, includes 30 tablets in the package, and is for prescription use only. It features dosage and storage instructions, a caution about dispensing without a prescription, and warnings about serious bleeding risks from overdose. The label also shows the NDC 51138-061-30 and repackager contact information.*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
Warfarin Sodium Tablets, USP Crystalline 10 mg by Med-Health Pharma, LLC. The label states the package contains 30 tablets. It includes a warning that Warfarin is a highly potent anticoagulant with serious bleeding risk from overdose and advises reading accompanying directions. Storage instructions indicate controlled room temperature between 20°-25°C (68°-77°F). Manufacturer details show Taro Pharmaceutical Industries, Haifa Bay, Israel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.